Advanced glycation endproducts and their pathogenic roles in neurological disorders.
about
The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor functionRole of methylglyoxal in Alzheimer's diseaseEdaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cellsAdvanced glycation endproducts interfere with adhesion and neurite outgrowthInhibition of Cardiac Hypertrophy Effects in D-Galactose-Induced Senescent Hearts by Alpinate Oxyphyllae Fructus Treatment.On the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson's Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine.Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease.Methylglyoxal, the dark side of glycolysisAdvanced glycation end product level, diabetes, and accelerated cognitive aging.Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.Anti-Apoptotic and Pro-Survival Effect of Alpinate Oxyphyllae Fructus (AOF) in a d-Galactose-Induced Aging Heart.Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication for theranostics.Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.Reducing methylglyoxal as a therapeutic target for diabetic heart disease.Oxidative stress, protein glycation and nutrition--interactions relevant to health and disease throughout the lifecycle.Synthesis of stable isotope-labelled monolysyl advanced glycation endproducts.Glycation of Liver Cystatin: Implication on its Structure and Function.Protein modification by dicarbonyl molecular species in neurodegenerative diseases.Type 2 diabetes mellitus and biomarkers of neurodegeneration.Erythropoietin attenuates advanced glycation endproducts-induced toxicity of Schwann cells in vitro.Featured Article: Pyruvate preserves antiglycation defenses in porcine brain after cardiac arrest.Defense Against Reactive Carbonyl Species Involves at Least Three Subcellular Compartments where Individual Components of the System Respond to Cellular Sugar Status.Human Co-culture Model of Neurons and Astrocytes to Test Acute Cytotoxicity of Neurotoxic Compounds.The oral administration of D-galactose induces abnormalities within the mitochondrial respiratory chain in the brain of rats.AGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression.Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways.Investigation Into the Effects of Tenilsetam on Markers of Neuroinflammation in GFAP-IL6 Mice.Asn-Trp dipeptides improve the oxidative stress and learning dysfunctions in D-galactose-induced BALB/c mice.Changes in Cerebrospinal Fluid Tau and β-Amyloid Levels in Diabetic and Prediabetic Patients: A Meta-Analysis
P2860
Q26767495-69A695A3-FAEC-4C97-89BE-BF4A09B59860Q27004644-0D89443F-1730-4481-956A-6F6F8246EB05Q27322912-DCADA64A-890A-48AC-B3DC-C6FDC0E77998Q28544858-50B28AD3-E707-4409-AF30-8B8C7FEF5A7CQ33578724-A64EE2FF-49E4-4ABA-AC17-F84B3B654A92Q33714263-61ACB698-5C67-4C91-8AFD-BECF59044DC6Q34291417-23AE303B-2C29-4CBF-A8AF-9B60DA2A7E94Q35063131-59C24F4E-C87E-4AC4-80B0-7154833F6D6AQ35240099-685F0C38-192E-4F7A-8814-D81A4E0BE3FEQ35896615-BC803BE4-38D2-40E4-B7FF-3D638891B886Q36846937-F2F8704D-D11A-4346-99BC-3FD5DF4B4746Q37214469-ECD1BBFC-2ECD-4FB4-9671-427B72EB6323Q38038126-35ECF380-392D-4EFA-844D-4FB6DBEF7855Q38197358-7E6D8B97-5650-499F-8648-EC04EFAEA86BQ38216061-7BBE1EBC-C881-4056-8CD3-C05384096333Q39434762-5BD7BCF4-1204-42E8-9405-253910547B7FQ39649360-EF92E243-C7BD-48DD-8F27-B2344BA76294Q40973301-90836964-F2F9-4189-B32A-96FA61959B42Q41531923-653B8A17-2AD1-4397-92A3-9F54134AD4E3Q41587516-DB78874E-9DA6-4936-81FB-2200A1FEFB68Q42989239-7DC22BAE-3195-4C58-8199-E2ADF947BEB4Q46259274-91C54241-7B74-489F-9D30-72F27905E7AEQ47447918-85456120-9C47-460E-99A0-A58D5CC2EC2FQ47965546-A0F9E42F-7824-4105-8E5B-19E074115049Q48129676-822A85CE-CCA9-43EE-BC79-EFDF6FEA5524Q48290344-0F31CA30-7F54-48A4-A712-2DD282EB646FQ48300482-2291BC2E-898B-45A5-BE59-B59EAD3B35BCQ48641183-0D0F7C8F-4ACE-4E40-9289-746E5126E3F0Q58572568-3E9FF2CB-BD5C-44C1-9BEC-1678A123AA3C
P2860
Advanced glycation endproducts and their pathogenic roles in neurological disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advanced glycation endproducts and their pathogenic roles in neurological disorders.
@en
Advanced glycation endproducts and their pathogenic roles in neurological disorders.
@nl
type
label
Advanced glycation endproducts and their pathogenic roles in neurological disorders.
@en
Advanced glycation endproducts and their pathogenic roles in neurological disorders.
@nl
prefLabel
Advanced glycation endproducts and their pathogenic roles in neurological disorders.
@en
Advanced glycation endproducts and their pathogenic roles in neurological disorders.
@nl
P2093
P2860
P1433
P1476
Advanced glycation endproducts and their pathogenic roles in neurological disorders.
@en
P2093
Alejandro Gugliucci
Bernadette Westcott
Gerald Münch
Teresita Menini
P2860
P2888
P304
P356
10.1007/S00726-010-0777-Y
P577
2010-10-14T00:00:00Z